Op poisoning treatment
Reading File
Finding Sources
Finding Sources
Searching PubMed
organophosphate poisoning treatment atropine pralidoxime
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, detailed content from multiple authoritative sources. Here is the full treatment guide:
Organophosphate (OP) Poisoning - Treatment
Mechanism of Toxicity
Organophosphates inhibit acetylcholinesterase (AChE), causing accumulation of acetylcholine (ACh) at:
- Muscarinic receptors - glands, smooth muscle, cardiac
- Nicotinic receptors - neuromuscular junction, sympathetic ganglia
- CNS receptors - seizures, coma
Death is primarily from respiratory failure - bronchorrhea + respiratory muscle paralysis.
Recognizing the Toxidrome
SLUDGE / DUMBELS (muscarinic effects):
| Mnemonic | Symptoms |
|---|---|
| Salivation, Lacrimation, Urination, Defecation/Diaphoresis, GI cramps, Emesis | Classic secretory signs |
| (Killer) Bs | Bronchorrhea, Bronchospasm, Bradycardia |
Nicotinic effects: Muscle fasciculations, weakness, paralysis, tachycardia (may override bradycardia), hypertension, mydriasis
CNS effects: Tremor, headache, confusion, hallucinations, seizures, coma
Treatment: Four Goals
- Decontamination
- Supportive care / airway stabilization
- Reverse ACh excess (Atropine)
- Reverse toxin binding at AChE (Pralidoxime/2-PAM)
Step 1 - Decontamination
- Remove ALL clothing (dermal absorption is a major route) - destroy contaminated clothing
- Flush exposed skin thoroughly with water (preferred); dry agents like flour, sand, or bentonite are alternatives
- Caregivers must wear PPE (full-face air purifier mask, chemical-resistant suit, nitrile/butyl rubber gloves, boots - Level C minimum)
- Gastric lavage and activated charcoal are generally NOT recommended - cholinergics absorb rapidly and profuse vomiting/diarrhea occur early
- Equipment (not skin) can be washed with 5% hypochlorite solution
Step 2 - Supportive Care (Airway Priority)
- Suction secretions and vomitus aggressively
- Provide supplemental O2 and ventilatory support
- Secure airway early if needed
- Avoid succinylcholine if possible - it is metabolized by cholinesterases and can have prolonged effect (4-6 hours) in OP poisoning; prefer rocuronium 1 mg/kg (nondepolarizing, not cholinesterase-metabolized)
- If succinylcholine must be used (1.5 mg/kg), anticipate prolonged sedation and ventilatory support
- Avoid beta-blockers - tachydysrhythmias resolve once cholinergic excess is treated
- Avoid ester anesthetics - may potentiate poisoning
- Treat agitation, seizures, coma with benzodiazepines after airway is secured
Step 3 - Atropine (Antidote #1)
Atropine is a competitive muscarinic receptor antagonist. It blocks muscarinic effects but NOT nicotinic effects (does not reverse paralysis or fasciculations).
Dosing:
| Patient | Initial Dose | Titration |
|---|---|---|
| Adults | 1-3 mg IV | Double every 5 minutes |
| Children | 0.05 mg/kg IV | Double every 5 minutes |
| Severe cases | Up to 200-500 mg in first hour |
- May be given IM if IV/IO access not yet established
- Once controlled: start infusion at 10-20% of total cumulative dose per hour
Endpoint of Atropinization (NOT heart rate or pupil size):
- Drying of respiratory secretions (most important)
- Easing of respiratory effort
- Resolution of bronchospasm/bronchorrhea
Tachycardia and mydriasis may occur at therapeutic doses - do NOT stop therapy for these. Over-atropinization causes anticholinergic toxidrome (hyperthermia, dry flushed skin, urinary retention, delirium).
Step 4 - Pralidoxime / 2-PAM (Antidote #2)
Pralidoxime reactivates AChE by displacing the organophosphate from the enzyme active site. Must be given early - delayed treatment leads to "aging" (irreversible covalent bond between OP and AChE), after which 2-PAM is ineffective.
Dosing:
| Guideline | Dose |
|---|---|
| Rosen's (standard) | 1-2 g IV bolus (25-50 mg/kg in children) |
| WHO recommendation | 30 mg/kg IV bolus, then 8 mg/kg/hr infusion |
| Maintenance | Continue infusion for 24-48 hours; monitor AChE levels |
- Indicated when: hemodynamic instability, large exposures, or requiring large/repeated atropine doses
- NOT recommended for: asymptomatic patients or carbamate exposures with minimal symptoms
- Evidence: theoretical benefit is well-established, though clinical trials have not shown clear mortality reduction (current evidence is inconclusive)
Seizure Management
- Airway protection + oxygen + atropine + benzodiazepines
- Atropine alone may prevent/abort early cholinergic seizures
- Avoid succinylcholine (may mask seizure activity through paralysis)
Special Syndromes
| Syndrome | Timing | Features |
|---|---|---|
| Acute cholinergic crisis | Immediate | Classic SLUDGE/DUMBELS |
| Intermediate syndrome | 1-5 days post-exposure (up to 40% of ingestions) | Proximal limb weakness, neck flexor paralysis, cranial nerve palsies, respiratory muscle paralysis - NO cholinergic signs; needs respiratory support |
| Delayed neuropathy (OPIDN) | Weeks later | Symmetrical sensorimotor axonopathy, leg cramps progressing to weakness/paralysis (mimics Guillain-Barré) |
Adjunct Therapies (Emerging Evidence)
- Magnesium sulfate and calcium channel blockers have some evidence as co-adjuvant treatments (2025 systematic review - PMID 40792609), but are not yet recommended for routine clinical use
- No role for hemodialysis or other enhanced elimination methods
Disposition
| Severity | Disposition |
|---|---|
| Minimal exposure | Decontaminate + observe 6-8 hours in ED |
| Significant poisoning | ICU admission |
| Recovery | Most recover within 10 days if treated early with no anoxic brain injury |
| Fat-soluble OPs | May require prolonged pralidoxime infusion for weeks |
End point of pralidoxime therapy: Absence of signs/symptoms when drug is withheld.
Summary Table: Key Drugs
| Drug | Mechanism | Dose | Treats |
|---|---|---|---|
| Atropine | Competitive muscarinic antagonist | 1-3 mg IV, double q5min; titrate to dry secretions | Muscarinic effects (secretions, bronchospasm, bradycardia) |
| Pralidoxime (2-PAM) | AChE reactivator | 1-2 g IV bolus, then infusion | Nicotinic + muscarinic (if given early) |
| Benzodiazepines | GABA agonist | Standard doses | Seizures |
| Rocuronium | Non-depolarizing NMB | 1 mg/kg | RSI (preferred over succinylcholine) |
Sources: Tintinalli's Emergency Medicine, p. 1343; Rosen's Emergency Medicine, p. 3029; Tietz Textbook of Laboratory Medicine, 7th ed.
Recent evidence note (2025): A meta-analysis (PMID 40792609) found some benefit for magnesium sulfate and/or calcium channel blockers as co-adjuvants, but these are not yet standard of care. The role of pralidoxime in reducing mortality remains controversial per current trials.
This is a shared conversation. Sign in to Orris to start your own chat.